Celularity Inc. Class A Common Stock
€0.73789
EUR
Last updated on --.
24h volume34.25K
24h highest0.88536 EUR
24h lowest0.73780 EUR
24h Price movement-2.54%
CELU recent prices
24 Hours
-2.54%-€0.01927
30 days
-3.39%-€0.025866
60 days
-37.95%-€0.45127
90 days
-31.99%-€0.34711
Key data
Previous close0.75716 EUR
Market cap25.38M EUR
Volume34.25K
P/E ratio--
Dividend yield (TTM)0.00%
Dividend amount--
Next ex-dividend date--
Next payment date--
EPS diluted (TTM)-2.7516 EUR
Net income (FY)-79.61M EUR
Revenue (FY)23.05M EUR
Last report dateApr 30, 2026
About Celularity Inc. Class A Common Stock
HeadquartersFLORHAM PARK
Employees (FY)115.00
Revenue per employee (FY)200.39K EUR
Net income per employee (FY)-692.26K EUR
Listed onNasdaq
CELU conversion tables
 |  |
|---|---|
| 0.5 CELU | 0.36894 EUR |
| 1 CELU | 0.73789 EUR |
| 5 CELU | 3.689 EUR |
| 10 CELU | 7.378 EUR |
| |
|---|---|
| 0.5 EUR | 0.67761 CELU |
| 1 EUR | 1.355 CELU |
| 5 EUR | 6.776 CELU |
| 10 EUR | 13.55 CELU |
More to explore
Trending stock
Trending stock PERP
Trending stock token
FAQ
CELU is trading at €0.73789, -2.54% over the last 24 hours. Track live moves on the price chart at the top of this page.
The CELU stock forecast depends on a mix of factors — broader market conditions, sector trends, and company-specific drivers like earnings, product cycles, and macro signals. CELU is currently trading at €0.73789, -2.54% over the last 24 hours, which reflects how the market is pricing these factors today. For a longer-term outlook on CELU price action, review the 30-day, 60-day, and 90-day performance shown above, monitor momentum across the PHARMACEUTICAL PREPARATIONS sector, and watch overall market sentiment. Stock forecasts and price predictions are inherently uncertain — always DYOR.
P/E ratio (Price-to-Earnings, trailing twelve months) measures how much investors pay per dollar of earnings over the last 12 months. CELU's P/E ratio is currently -- — calculated by dividing its share price by its trailing 12-month earnings per share (EPS). A higher P/E suggests investors expect stronger future growth from CELU; a lower P/E may indicate the stock is undervalued or that the market is pricing in a weaker outlook. P/E ratios are most useful when compared against CELU's historical range and other companies in the PHARMACEUTICAL PREPARATIONS sector.
Celularity Inc. Class A Common Stock's market cap is currently 25.38M EUR. Market cap is calculated as stock price × total shares outstanding.
Disclaimer
The social content on this page ("Content"), including but not limited to tweets and statistics provided by LunarCrush, is sourced from third parties and provided "as is" for informational purposes only. OKX does not guarantee the quality or accuracy of the Content, and the Content does not represent the views of OKX. It is not intended to provide (i) investment advice or recommendation; (ii) an offer or solicitation to buy, sell or hold digital assets; or (iii) financial, accounting, legal or tax advice. Digital assets, including stablecoins and NFTs, involve a high degree of risk and can fluctuate greatly. The price and performance of the digital assets are not guaranteed and may change without notice.
OKX does not provide investment or asset recommendations. You should carefully consider whether trading or holding digital assets is suitable for you in light of your financial condition. Please consult your legal/tax/investment professional for questions about your specific circumstances. For further details, please refer to our Terms of Use and Risk Warning.
OKX does not provide investment or asset recommendations. You should carefully consider whether trading or holding digital assets is suitable for you in light of your financial condition. Please consult your legal/tax/investment professional for questions about your specific circumstances. For further details, please refer to our Terms of Use and Risk Warning.
24h volume34.25K
24h highest0.88536 EUR
24h lowest0.73780 EUR
24h Price movement-2.54%
Start trade with CELU Perpetual
Sign up to trade